Thomas M Moriarty
CIK 1412221 · View on SEC EDGAR ↗
First SEC filing: April 3, 2014 · Latest: April 3, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 27, 2026 | ACI | P | 170,500 | $11.51 | $1,962,455 | 308,946 Direct | +123.15% | Acquired | 3.9% (price as of 2026-08-20) |
| Dec. 15, 2022 | CVS | S 10b5-1 | 36,490 | $98.24 | $3,584,778 | 608,129 Direct | -5.66% | Disposed | -4.3% (price as of 2026-08-20) |
| Dec. 15, 2022 | CVS | S 10b5-1 | 100,976 | $98.40 | $9,936,038 | 608,129 Direct | -14.24% | Disposed | -4.4% (price as of 2026-08-20) |
| June 28, 2022 | CVS | S 10b5-1 | 38,873 | $95.00 | $3,692,935 | 626,273 Direct | -5.84% | Disposed | -1.0% (price as of 2026-08-20) |
| June 28, 2022 | CVS | S 10b5-1 | 50,502 | $95.00 | $4,797,690 | 626,273 Direct | -7.46% | Disposed | -1.0% (price as of 2026-08-20) |
| June 28, 2022 | CVS | S 10b5-1 | 49,279 | $95.00 | $4,681,505 | 626,273 Direct | -7.29% | Disposed | -1.0% (price as of 2026-08-20) |
| March 15, 2022 | CVS | S 10b5-1 | 51,361 | $105.00 | $5,392,905 | 836,751 Direct | -5.78% | Disposed | -10.4% (price as of 2026-08-20) |
| May 10, 2021 | CVS | S 10b5-1 | 109,469 | $86.00 | $9,414,334 | 0 Direct | -100.00% | Disposed | 9.3% (price as of 2026-08-20) |
| April 21, 2021 | CVS | S 10b5-1 | 2,420 | $77.00 | $186,340 | 0 Direct | -100.00% | Disposed | 22.1% (price as of 2026-08-20) |
| April 21, 2021 | CVS | S 10b5-1 | 101,003 | $77.00 | $7,777,231 | 2,420 Direct | -97.66% | Disposed | 22.1% (price as of 2026-08-20) |
| March 29, 2021 | CVS | S 10b5-1 | 62,943 | $76.15 | $4,793,109 | 0 Direct | -100.00% | Disposed | 23.5% (price as of 2026-08-20) |
| March 19, 2021 | CVS | S 10b5-1 | 49,211 | $74.15 | $3,648,996 | 18,226 Indirect | -72.97% | Disposed | 26.8% (price as of 2026-08-20) |
| Oct. 2, 2017 | CVS | S 10b5-1 | 20,547 | $81.17 | $1,667,800 | 22,631 Direct | -47.59% | Disposed | 15.9% (price as of 2026-08-20) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 49,174 | $79.61 | $3,914,742 | 29,009 Direct | -62.90% | Disposed | 18.1% (price as of 2026-08-20) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 41,093 | $79.61 | $3,271,414 | 29,009 Direct | -58.62% | Disposed | 18.1% (price as of 2026-08-20) |
Showing latest 100 of 116 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | ACI | Dividend Equivalent Units | Class A common stock, par value $0.01 (406) | — | — | 406 | Acquired |
| Aug. 7, 2026 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (2,426) | — | — | 2,426 | Acquired |
| Aug. 7, 2026 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (422) | — | — | 422 | Acquired |
| Aug. 7, 2026 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (782) | — | — | 782 | Acquired |
| Aug. 7, 2026 | ACI | Dividend Equivalent Units | Time-based Restricted StockUnits (1,573) | — | — | 1,573 | Acquired |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (1,177) | — | — | 1,177 | Disposed |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (1,263) | — | — | 1,263 | Disposed |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (1,263) | — | — | 1,263 | Disposed |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (1,171) | — | — | 1,171 | Disposed |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (1,171) | — | — | 1,171 | Disposed |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (1,171) | — | — | 1,171 | Disposed |
| Dec. 1, 2025 | ACI | Time-based Restricted Stock Units | Class A common stock par value $0.01 (7,259) | — | — | 7,259 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (1,296) | — | — | 1,296 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (941) | — | — | 941 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (0) | — | — | 941 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (1,027) | — | — | 1,027 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (0) | — | — | 1,027 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (0) | — | — | 1,027 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (0) | — | — | 1,027 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (0) | — | — | 1,027 | Disposed |
| Dec. 1, 2025 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (0) | — | — | 1,027 | Disposed |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock, par value $0.01 (238) | — | — | 238 | Acquired |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock, par value $0.01 (512) | — | — | 512 | Acquired |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock, par value $0.01 (711) | — | — | 711 | Acquired |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock, par value $0.01 (1,472) | — | — | 1,472 | Acquired |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (262) | — | — | 262 | Acquired |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (190) | — | — | 190 | Acquired |
| Nov. 7, 2025 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (208) | — | — | 208 | Acquired |
| Feb. 9, 2024 | ACI | Dividend Equivalent Units | Class A common stock, par value $0.01 (457) | — | — | 457 | Acquired |
| Nov. 14, 2023 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (451) | — | — | 451 | Acquired |
| Aug. 10, 2023 | ACI | Dividend Equivalent Units | Class A common stock par value $0.01 (440) | — | — | 440 | Acquired |
| July 3, 2023 | ACI | Performance-Based Restricted Stock Units | Class A common stock par value $0.01 (79,872) | — | — | 79,872 | Acquired |
| July 3, 2023 | ACI | Time-Based Restricted Stock Units | Class A common stock par value $0.01 (79,872) | — | — | 79,872 | Acquired |
| Dec. 15, 2022 | CVS | Stock Option | Common Stock (36,490) | $62.21 | April 1, 2025 | 36,490 | Disposed |
| Dec. 15, 2022 | CVS | Stock Option | Common Stock (100,976) | $78.05 | April 3, 2024 | 100,976 | Disposed |
| June 28, 2022 | CVS | Stock Option | Common Stock (49,279) | — | April 1, 2030 | 49,279 | Disposed |
| June 28, 2022 | CVS | Stock Option [F5] | Common Stock (38,873) | $74.30 | April 1, 2031 | 38,873 | Disposed |
| June 28, 2022 | CVS | Stock Option | Common Stock (50,502) | $54.19 | April 1, 2029 | 50,502 | Disposed |
| April 1, 2022 | CVS | Stock Option | Common Stock (46,777) | $101.09 | April 1, 2032 | 46,777 | Acquired |
| March 15, 2022 | CVS | Stock Option | Common Stock (51,361) | $102.26 | April 1, 2022 | 51,361 | Disposed |
| May 10, 2021 | CVS | Stock Option | Common Stock (109,469) | $62.21 | April 1, 2025 | 109,469 | Disposed |
| May 4, 2021 | CVS | Stock Option | Common Stock (49,279) | — | April 1, 2030 | 49,279 | Disposed |
| April 21, 2021 | CVS | Stock Option | Common Stock (101,003) | $54.19 | April 1, 2029 | 101,003 | Disposed |
| April 1, 2021 | CVS | Stock Option | Common Stock (155,495) | $74.30 | April 1, 2031 | 155,495 | Acquired |
| March 29, 2021 | CVS | Stock Option | Common Stock (62,943) | $74.29 | April 1, 2021 | 62,943 | Disposed |
| April 1, 2020 | CVS | Stock Option | Common Stock (197,116) | — | April 1, 2030 | 197,116 | Acquired |
| April 1, 2020 | CVS | Stock Option | Common Stock (197,116) | — | April 1, 2030 | 197,116 | Acquired |
| April 1, 2019 | CVS | Stock Option | Common Stock (202,007) | $54.19 | April 1, 2029 | 202,007 | Acquired |
| April 1, 2018 | CVS | Stock Option | Common Stock (145,959) | $62.21 | April 1, 2025 | 145,959 | Acquired |
| Oct. 2, 2017 | CVS | Stock Option | Common Stock (20,547) | $48.67 | Oct. 1, 2022 | 20,547 | Disposed |
| Sept. 11, 2017 | CVS | Stock Option | Common Stock (49,174) | $54.53 | April 1, 2020 | 49,174 | Disposed |
| Sept. 11, 2017 | CVS | Stock Option | Common Stock (41,093) | $48.67 | Oct. 1, 2022 | 41,093 | Disposed |
| April 3, 2017 | CVS | Stock Option | Common Stock (125,224) | $78.05 | April 3, 2024 | 125,224 | Acquired |
| April 1, 2016 | CVS | Stock Option | Common Stock (71,696) | $104.82 | April 1, 2023 | 71,696 | Acquired |
| April 1, 2015 | CVS | Stock Option | Common Stock (51,361) | $102.26 | April 1, 2022 | 51,361 | Acquired |
| April 1, 2014 | CVS | Stock Option | Common Stock (62,943) | $74.29 | April 1, 2021 | 62,943 | Acquired |
| April 1, 2013 | CVS | Stock Option | Common Stock (49,174) | $54.53 | April 1, 2020 | 49,174 | Acquired |
| Oct. 1, 2012 | CVS | Stock Option | Common Stock (61,640) | $48.67 | Oct. 1, 2022 | 61,640 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $670,000 | — | — | — | $2,412,573 | — | — | $5,415,722 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.